Physician profile
Ronald Shane Day
NPI 1174599476
$838.20
in general payments reported to CMS, 2019-2025
12 companies · $339 in 2025
The $339 reported for 2025 was more than what 83% of Aerospace Medicine providers received nationally (typical 2025 total: $89.75).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $120 · 2023: $349 · 2024: $31.27 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bsn Medical INC | $258.30 | 2022-2023 | |
| Urgo Medical North America, LLC | $251.27 | 2025 | Urgoclean Ag |
| Kci USA, INC. | $95.88 | 2022-2023 | Activ.A.C., V.A.C. Veraflo, Promogran Prisma |
| Mimedx Group, INC. | $67.47 | 2025 | |
| Solventum Corporation | $31.27 | 2024 | Activ.A.C., Promogran Prisma, V.A.C. Veraflo |
| Convatec INC. | $27.37 | 2022 | |
| Medline Industries Lp | $22.01 | 2022 | |
| Hollister Incorporated | $19.94 | 2025 | New Image |
| Integra Lifesciences Corporation | $18.51 | 2023 | Tcc-Ez |
| Abbvie INC. | $16.64 | 2023 | Dalvance |
| Kerecis Limited | $16.39 | 2022 | |
| Smith+Nephew, INC. | $13.15 | 2023 | Oasis, Grafix Pl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.